Tech Company Financing Transactions

Denali Therapeutics Funding Round

Denali Therapeutics closed a $217 million financing round on 5/15/2015. Investors included Alaska Permanent Fund, Arch Venture Partners and F-Prime Capital.

Transaction Overview

Announced On
5/15/2015
Transaction Type
Venture Equity
Amount
$217,000,000
Round
Undisclosed
Proceeds Purpose
The company will use the funds to discover and develop effective medicines for Alzheimer's disease, Parkinson's disease, ALS and other neurodegenerative diseases.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
161 Oyster Point Blvd.
San Francisco, CA 94080
USA
Phone
Undisclosed
Email Address
Overview
Denali (NASDAQ: DNLI) was founded on the collaboration of leading scientists, industry experts and investors who share the vision that scientific discovery energetically applied to translational medicine is the key to delivering effective therapies to patients.
Profile
Denali Therapeutics LinkedIn Company Profile
Social Media
Denali Therapeutics Company Twitter Account
Company News
Denali Therapeutics News
Facebook
Denali Therapeutics on Facebook
YouTube
Denali Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Ryan Watts
  Ryan Watts LinkedIn Profile  Ryan Watts Twitter Account  Ryan Watts News  Ryan Watts on Facebook
Chief Financial Officer
Steve krognes
  Steve krognes LinkedIn Profile  Steve krognes Twitter Account  Steve krognes News  Steve krognes on Facebook
Chief Medical Officer
Carole Ho
  Carole Ho LinkedIn Profile  Carole Ho Twitter Account  Carole Ho News  Carole Ho on Facebook
Chief Operating Officer
Alexander Schuth
  Alexander Schuth LinkedIn Profile  Alexander Schuth Twitter Account  Alexander Schuth News  Alexander Schuth on Facebook
VP - Human Resources
Cindy Dunkle
  Cindy Dunkle LinkedIn Profile  Cindy Dunkle Twitter Account  Cindy Dunkle News  Cindy Dunkle on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/15/2015: Ineda Systems venture capital transaction
Next: 5/15/2015: Silversheet venture capital transaction

 

Share this article

 


Where The Data Comes From

We record tech company VC transactions. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary